Immix Biopharma, Inc. IMMX Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s shares (basic)?
- Immix Biopharma, Inc. (IMMX) reported shares (basic) of 55.4M in Q1 2026.
- How has Immix Biopharma, Inc.'s shares (basic) changed year-over-year?
- Immix Biopharma, Inc.'s shares (basic) increased by 86.4% year-over-year, from 29.7M to 55.4M.
- What is the long-term trend for Immix Biopharma, Inc.'s shares (basic)?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s shares (basic) has grown at a 73.3% compound annual growth rate (CAGR), from 13.8M to 124.6M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.